HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paula M Canas Selected Research

alpha,beta-methyleneadenosine 5'-diphosphate

1/2019Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A2A receptor over-activation in a rat model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paula M Canas Research Topics

Disease

10Alzheimer Disease (Alzheimer's Disease)
01/2022 - 04/2008
5Gliosis
01/2022 - 11/2009
5Memory Disorders (Memory Loss)
01/2018 - 04/2008
4Parkinson Disease (Parkinson's Disease)
01/2019 - 03/2008
3Cognitive Dysfunction
01/2018 - 11/2009
2Angelman Syndrome (Syndrome, Angelman)
06/2021 - 12/2020
2Neuroinflammatory Diseases
01/2021 - 04/2011
2Brain Diseases (Brain Disorder)
01/2021 - 12/2020
2Huntington Disease (Huntington's Disease)
01/2020 - 11/2009
2Neuroblastoma
01/2019 - 06/2014
1Mood Disorders (Mood Disorder)
01/2022
1Ataxia (Dyssynergia)
06/2021
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021
1Epilepsy (Aura)
01/2021
1Ischemia
01/2021
1Intellectual Disability (Idiocy)
12/2020
1Neurodevelopmental Disorders
12/2020
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018
1Temporal Lobe Epilepsy
11/2018
1Dementia (Dementias)
01/2018
1Parkinsonian Disorders (Parkinsonism)
06/2014
1Anhedonia
01/2014
1Tetanus
04/2011
1Mitochondrial Diseases (Mitochondrial Disease)
11/2009
1Amnesia (Dissociative Amnesia)
04/2008

Drug/Important Bio-Agent (IBA)

11Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
01/2022 - 03/2008
6Peptides (Polypeptides)IBA
01/2022 - 04/2008
6Adenosine (Adenocard)FDA LinkGeneric
01/2021 - 11/2018
5Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2014
4Proteins (Proteins, Gene)FDA Link
06/2021 - 01/2018
4Adenosine Triphosphate (ATP)IBA
01/2021 - 01/2019
35- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
02/2015 - 04/2008
2Caffeine (No Doz)FDA LinkGeneric
09/2020 - 04/2008
2Purinergic P1 Receptor AntagonistsIBA
09/2020 - 04/2008
2Dopamine (Intropin)FDA LinkGeneric
01/2019 - 06/2014
2Oxidopamine (6 Hydroxydopamine)IBA
01/2019 - 06/2014
2Qa-SNARE Proteins (Syntaxin)IBA
01/2018 - 01/2018
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
05/2016 - 03/2008
2Amyloid beta-PeptidesIBA
11/2009 - 04/2008
1GlucocorticoidsIBA
01/2022
1Glutamic Acid (Glutamate)FDA Link
01/2021
1LigandsIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Drinking WaterIBA
09/2020
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2020
1AntioxidantsIBA
01/2020
1alpha,beta-methyleneadenosine 5'-diphosphateIBA
01/2019
1Adenosine Diphosphate (ADP)IBA
01/2019
1Kainic Acid (Kainate)IBA
11/2018
1anandamide (arachidonylethanolamide)IBA
01/2018
1SynaptophysinIBA
01/2018
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2018
1Streptozocin (Streptozotocin)FDA Link
01/2018
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2017
1Caspase 3 (Caspase-3)IBA
01/2017
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
05/2016
1SCH 23390IBA
02/2015
1coomassie Brilliant BlueIBA
06/2014
13- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA
06/2014
1Purinergic P2X7 ReceptorsIBA
06/2014
1ApomorphineFDA Link
06/2014
1Sucrose (Saccharose)IBA
01/2014
1LipopolysaccharidesIBA
04/2011
1amyloid beta-protein (1-42)IBA
11/2009
1SpermineIBA
11/2009
1Quinolinic AcidIBA
11/2009
1fluoro-jade CIBA
11/2009
1PolyaminesIBA
11/2009
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
03/2009
1Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2008
1Cholinergic Agents (Cholinergics)IBA
10/2008
1Dizocilpine Maleate (Dizocilpine)IBA
04/2008
1Scopolamine (Hyoscine)FDA Link
04/2008
1Adenosine A2 Receptor AntagonistsIBA
04/2008
1Neuroprotective AgentsIBA
03/2008

Therapy/Procedure

1Injections
11/2009